View in EDS

High frequency of CD95+/CD45RA- regulatory T cells defines an immunosuppressive profile associated with MDS progression.

Saved in:
Bibliographic Details
Title: High frequency of CD95+/CD45RA- regulatory T cells defines an immunosuppressive profile associated with MDS progression.
Authors: Vazquez R; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Deredec N; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Boussaid I; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Boncoeur P; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France., Knosp C; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Houvert A; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Zalmai L; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France., Friedrich C; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Almire C; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Dussiau C; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Willems L; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Clinique, Hôpital Cochin, Paris, France., Birsen R; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Clinique, Hôpital Cochin, Paris, France., Decroocq J; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Clinique, Hôpital Cochin, Paris, France., Bouscary D; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Clinique, Hôpital Cochin, Paris, France., Kosmider O; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France., Kordasti S; Comprehensive Cancer Centre, King's College, London, UK.; International Integrative Innovative Immunology for MDS (i4MDS) Consortium., Fontenay M; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; International Integrative Innovative Immunology for MDS (i4MDS) Consortium., Simoni Y; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; International Integrative Innovative Immunology for MDS (i4MDS) Consortium., Chapuis N; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; International Integrative Innovative Immunology for MDS (i4MDS) Consortium.
Source: British journal of haematology [Br J Haematol] 2026 Jun; Vol. 208 (6), pp. 1993-2003. Date of Electronic Publication: 2026 May 04.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42080308
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: High frequency of CD95<superscript>+</superscript>/CD45RA<superscript>-</superscript> regulatory T cells defines an immunosuppressive profile associated with MDS progression.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vazquez+R%22">Vazquez R</searchLink>; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Deredec+N%22">Deredec N</searchLink>; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Boussaid+I%22">Boussaid I</searchLink>; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Boncoeur+P%22">Boncoeur P</searchLink>; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.<br /><searchLink fieldCode="AU" term="%22Knosp+C%22">Knosp C</searchLink>; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Houvert+A%22">Houvert A</searchLink>; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Zalmai+L%22">Zalmai L</searchLink>; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.<br /><searchLink fieldCode="AU" term="%22Friedrich+C%22">Friedrich C</searchLink>; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Almire+C%22">Almire C</searchLink>; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Dussiau+C%22">Dussiau C</searchLink>; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Willems+L%22">Willems L</searchLink>; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Clinique, Hôpital Cochin, Paris, France.<br /><searchLink fieldCode="AU" term="%22Birsen+R%22">Birsen R</searchLink>; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Clinique, Hôpital Cochin, Paris, France.<br /><searchLink fieldCode="AU" term="%22Decroocq+J%22">Decroocq J</searchLink>; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Clinique, Hôpital Cochin, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bouscary+D%22">Bouscary D</searchLink>; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Clinique, Hôpital Cochin, Paris, France.<br /><searchLink fieldCode="AU" term="%22Kosmider+O%22">Kosmider O</searchLink>; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Kordasti+S%22">Kordasti S</searchLink>; Comprehensive Cancer Centre, King's College, London, UK.; International Integrative Innovative Immunology for MDS (i4MDS) Consortium.<br /><searchLink fieldCode="AU" term="%22Fontenay+M%22">Fontenay M</searchLink>; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; International Integrative Innovative Immunology for MDS (i4MDS) Consortium.<br /><searchLink fieldCode="AU" term="%22Simoni+Y%22">Simoni Y</searchLink>; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; International Integrative Innovative Immunology for MDS (i4MDS) Consortium.<br /><searchLink fieldCode="AU" term="%22Chapuis+N%22">Chapuis N</searchLink>; Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.; Leukemia Institute Paris Saint-Louis, Paris, France.; International Integrative Innovative Immunology for MDS (i4MDS) Consortium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2026 Jun; Vol. 208 (6), pp. 1993-2003. <i>Date of Electronic Publication: </i>2026 May 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42080308
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bjh.70504
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1993
    Titles:
      – TitleFull: High frequency of CD95+/CD45RA- regulatory T cells defines an immunosuppressive profile associated with MDS progression.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vazquez R
      – PersonEntity:
          Name:
            NameFull: Deredec N
      – PersonEntity:
          Name:
            NameFull: Boussaid I
      – PersonEntity:
          Name:
            NameFull: Boncoeur P
      – PersonEntity:
          Name:
            NameFull: Knosp C
      – PersonEntity:
          Name:
            NameFull: Houvert A
      – PersonEntity:
          Name:
            NameFull: Zalmai L
      – PersonEntity:
          Name:
            NameFull: Friedrich C
      – PersonEntity:
          Name:
            NameFull: Almire C
      – PersonEntity:
          Name:
            NameFull: Dussiau C
      – PersonEntity:
          Name:
            NameFull: Willems L
      – PersonEntity:
          Name:
            NameFull: Birsen R
      – PersonEntity:
          Name:
            NameFull: Decroocq J
      – PersonEntity:
          Name:
            NameFull: Bouscary D
      – PersonEntity:
          Name:
            NameFull: Kosmider O
      – PersonEntity:
          Name:
            NameFull: Kordasti S
      – PersonEntity:
          Name:
            NameFull: Fontenay M
      – PersonEntity:
          Name:
            NameFull: Simoni Y
      – PersonEntity:
          Name:
            NameFull: Chapuis N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2141
          Numbering:
            – Type: volume
              Value: 208
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: British journal of haematology
              Type: main
ResultId 1